Vedolizumab Proves Its Worth in Treating Chronic Pouchitis

(MedPage Today) -- Vedolizumab (Entyvio) was more effective at inducing remission in patients with chronic pouchitis after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis compared with placebo, a randomized phase IV trial showed. Among...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news